Spirair

South San Francisco, United States

Spirair is a medical device company that offers minimally invasive solutions for nasal septum deviation treatment.

$12.8M raised

Aug 2025

Venture - Series Unknown

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Spirair

How much funding has Spirair raised?

Spirair has raised $12.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2025.

Where is Spirair headquartered?

Spirair is headquartered in South San Francisco, United States.

What does Spirair do?

Spirair is a medical device company that offers minimally invasive solutions for nasal septum deviation treatment.

What stage is Spirair at?

Spirair is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 12, 2025.

MLA

"Spirair — Funding & Investors." VCBacked, August 12, 2025, https://www.vcbacked.co/company/spirair. Accessed June 3, 2026.

APA

VCBacked. (2025). Spirair — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/spirair

Wikipedia (cite web)

{{cite web |title=Spirair — Funding & Investors |url=https://www.vcbacked.co/company/spirair |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 12, 2025.